Monocarboxylic-based phosphotyrosyl mimetics in the design of Grb2 SH2 domain inhibitors

被引:42
作者
Burke, TR
Luo, J
Yao, ZJ
Gao, Y
Zhao, H
Milne, GWA
Guo, RB
Voigt, JH
King, CR
Yang, DJ
机构
[1] NCI, Med Chem Lab, Div Basic Sci, NIH, Bethesda, MD 20892 USA
[2] Georgetown Univ, Med Ctr, Lombardi Canc Ctr, Washington, DC 20007 USA
基金
美国国家卫生研究院;
关键词
D O I
10.1016/S0960-894X(98)00740-9
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
Three monocarboxylic-containing analogues, O-carboxymethyltyrosine (cmT, 5), 4-(carboxymethyl)phenylalanine (cmF, 6), and 4-(carboxydifluoromethyl)phenylalanine (F(2)cmF, 7) were utilized as phosphotyrosyl (pTyr) replacements in a high affinity a-bend mimicking platform, where they exhibited IC50 values of 2.5 mu M, 65 mu M and 28 mu M, respectively, in a Grb2 SH2 domain Biacore binding assay. When a terminal Na-oxalyl axillary was utilized to enhance ligand interactions with a critical SH2 domain Arg67 residue (alpha A-helix), binding potencies increased from 4- to 10-fold, resulting in submicromolar affinity for cmF (IC50 = 0.6 mu M) and low micromolar affinity for F(2)cmF (IC50 = 2 mu M) Cell lysate binding studies also showed inhibition of cognate Grb2 binding to the p185(erbB-2) phosphoprotein in the same rank order of potency as observed in the Biacore assay. These results indicate the potential value of cmF and F(2)cmF residues as pTyr mimetics for the study of Grb2 SH2 domains and suggest new strategies for improvements in inhibitor design. (C) 1999 Published by Elsevier Science Ltd.
引用
收藏
页码:347 / 352
页数:6
相关论文
共 26 条
  • [1] BEAULIEU L, 1998, 216 NAT AM CHEM SOC
  • [2] Burke TR, 1997, CURR PHARM DESIGN, V3, P291
  • [3] 4'-O-[2-(2-fluoromalonyl)]-L-tyrosine: A phosphotyrosyl mimic for the preparation of signal transduction inhibitory peptides
    Burke, TR
    Ye, B
    Akamatsu, M
    Ford, H
    Yan, XJ
    Kole, HK
    Wolf, G
    Shoelson, SE
    Roller, PP
    [J]. JOURNAL OF MEDICINAL CHEMISTRY, 1996, 39 (05) : 1021 - 1027
  • [4] Enantioselective synthesis of nonphosphorus-containing phosphotyrosyl mimetics and their use in the preparation of tyrosine phosphatase inhibitory peptides
    Burke, TR
    Yao, ZJ
    Zhao, H
    Milne, GWA
    Wu, L
    Zhang, ZY
    Voigt, JH
    [J]. TETRAHEDRON, 1998, 54 (34) : 9981 - 9994
  • [5] NONHYDROLYZABLE PHOSPHOTYROSYL MIMETICS FOR THE PREPARATION OF PHOSPHATASE-RESISTANT SH2 DOMAIN INHIBITORS
    BURKE, TR
    SMYTH, MS
    OTAKA, A
    NOMIZU, M
    ROLLER, PP
    WOLF, G
    CASE, R
    SHOELSON, SE
    [J]. BIOCHEMISTRY, 1994, 33 (21) : 6490 - 6494
  • [6] Distinct tyrosine autophosphorylation sites negatively and positively modulate neu-mediated transformation
    Dankort, DL
    Wang, ZX
    Blackmore, V
    Moran, MF
    Muller, WJ
    [J]. MOLECULAR AND CELLULAR BIOLOGY, 1997, 17 (09) : 5410 - 5425
  • [7] RECOGNITION OF A HIGH-AFFINITY PHOSPHOTYROSYL PEPTIDE BY THE SRC HOMOLOGY-2 DOMAIN OF P56(LCK)
    ECK, MJ
    SHOELSON, SE
    HARRISON, SC
    [J]. NATURE, 1993, 362 (6415) : 87 - 91
  • [8] Discovery of 3-aminobenzyloxycarbonyl as an N-terminal group conferring high affinity to the minimal phosphopeptide sequence recognized by the Grb2-SH2 domain
    Furet, P
    Gay, B
    GarciaEcheverria, C
    Rahuel, J
    Fretz, H
    Schoepfer, J
    Caravatti, G
    [J]. JOURNAL OF MEDICINAL CHEMISTRY, 1997, 40 (22) : 3551 - 3556
  • [9] Structure-based design and synthesis of nigh affinity tripeptide ligands of the Grb2-SH2 domain
    Furet, P
    Gay, B
    Caravatti, G
    García-Echeverría, C
    Rahuel, J
    Schoepfer, J
    Fretz, H
    [J]. JOURNAL OF MEDICINAL CHEMISTRY, 1998, 41 (18) : 3442 - 3449
  • [10] Potent antagonists of the SH2 domain of Grb2:: Optimization of the X+1 position of 3-Amino-Z-Tyr(PO3H2)-X+1-Asn-NH2
    García-Echeverría, C
    Furet, P
    Gay, B
    Fretz, H
    Rahuel, J
    Schoepfer, J
    Caravatti, G
    [J]. JOURNAL OF MEDICINAL CHEMISTRY, 1998, 41 (11) : 1741 - 1744